Heme oxygenase and ocular disease: A review of the literature

Current Eye Research

Volumn 37, Issue 11, 2012, Pages 955-960

  Zhao, Jun ^a   Tan, Shaojian ^b   Liu, Fangyi ^a   Zhang, Yingqiu ^a   Su, Mingshan ^a   Sun, Ding ^a  

^a LINYI PEOPLE'S HOSPITAL   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cytoprotection; Heme oxygenase; Inflammation; Ocular disease; Review

Indexed keywords

BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; HEME; HEME OXYGENASE; HEME OXYGENASE 1; IRON; ISOENZYME;

APOPTOSIS; CELL PROTECTION; DIABETIC RETINOPATHY; EYE DISEASE; GLAUCOMA; HEALING; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; RETINA DEGENERATION; REVIEW;

ANIMALS; APOPTOSIS; CYTOPROTECTION; EYE DISEASES; HEME OXYGENASE (DECYCLIZING); HUMANS;

EID: 84866944599     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.700753     Document Type: Review

References (90)

1. Maines MD. The heme oxygenase system: past, present, and future. Antioxid Redox Signal 2004;6:797-801.
2. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997;37:517-554.
3. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006;86:583-650.
4. Simon T, Anegon I, Blancou P. Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer. Immunotherapy 2011;3:15-18.
5. Kim HP, Pae HO, Back SH et al. Heme oxygenase-1 comes back to endoplasmic reticulum. Biochem Biophys Res Commun 2011;404:1-5.
6. Fan W, Huang F, Zhu X et al. The heme oxygenase system and oral diseases. Oral Dis 2011;17:252-257.
7. Kim YM, Pae HO, Park JE et al. Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2011;14:137-167.
8. © reductase in human corneal epithelium. Invest Ophthalmol Vis Sci 1987;28:1464-1472.
9. Cao L, Blute TA, Eldred WD. Localization of heme oxy-genase-2 and modulation of cGMP levels by carbon monoxide and/or nitric oxide in the retina. Vis Neurosci 2000;17:319-329.
10. Nishimura RN, Dwyer BE, Lu SY. Localization of heme oxy-genase in rat retina: effect of light adaptation. Neurosci Lett 1996;205:13-16.
11. Ma N, Ding X, Doi M et al. Cellular and subcellular localization of heme oxygenase-2 in monkey retina. J Neurocytol 2004;33:407-415.
12. Li T, Zhang H, Liang F. Existence of heme oxygenase-carbon monoxide-cyclic guanosine monophosphate pathway in human trabecular meshwork cells in vitro. J Huazhong Univ Sci Technol Med Sci 2004;24:173-177.
13. Ohta K, Kikuchi T, Arai S et al. Protective role of heme oxy-genase-1 against endotoxin-induced uveitis in rats. Exp Eye Res 2003;77:665-673.
14. Neil TK, Stoltz RA, Jiang S et al. Modulation of corneal heme oxygenase expression by oxidative stress agents. J Ocul Pharmacol Ther 1995;11:455-468.
15. Laniado-Schwartzman M, Abraham NG, Conners M et al. Heme oxygenase induction with attenuation of experimentally induced corneal infammation. Biochem Pharmacol 1997;53:1069-1075.
16. Padgaonkar VA, Giblin FJ, Fowler K et al. Heme oxygenase synthesis is induced in cultured lens epithelium by hyper-baric oxygen or puromycin. Exp Eye Res 1997;65:435-443.
17. Rogers BS, Symons RC, Komeima K et al. Differential sensitivity of cones to iron-mediated oxidative damage. Invest Ophthalmol Vis Sci 2007;48:438-445.
18. Kutty G, Hayden B, Osawa Y et al. Heme oxygenase: expression in human retina and modulation by stress agents in a human retinoblastoma cell model system. Curr Eye Res 1992;11:153-160.
19. Ulyanova T, Szél A, Kutty RK et al. Oxidative stress induces heme oxygenase-1 immunoreactivity in Müller cells of mouse retina in organ culture. Invest Ophthalmol Vis Sci 2001;42:1370-1374.
20. Kutty RK, Kutty G, Wiggert B et al. Induction of heme oxy-genase 1 in the retina by intense visible light: suppression by the antioxidant dimethylthiourea. Proc Natl Acad Sci USA 1995;92:1177-1181.
21. Roehlecke C, Schaller A, Knels L et al. The infuence of sublethal blue light exposure on human RPE cells. Mol Vis 2009;15:1929-1938.
22. Rzymkiewicz DM, Reddan JR, Andley UP. Induction of heme oxygenase-1 modulates cis-aconitase activity in lens epithelial cells. Biochem Biophys Res Commun 2000;270:324-328.
23. Black AT, Gordon MK, Heck DE et al. UVB light regulates expression of antioxidants and infammatory mediators in human corneal epithelial cells. Biochem Pharmacol 2011;81:873-880.
24. Kutty RK, Nagineni CN, Kutty G et al. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol 1994;159:371-378.
25. Honda S, Hjelmeland LM, Handa JT. The use of hyperoxia to induce chronic mild oxidative stress in RPE cells in vitro. Mol Vis 2001;7:63-70.
26. Padgaonkar VA, Leverenz VR, Dang L et al. Thioredoxin reductase may be essential for the normal growth of hyper-baric oxygen-treated human lens epithelial cells. Exp Eye Res 2004;79:847-857.
27. Braunstein SG, Deramaudt TG, Rosenblum DG et al. Heme oxygenase-1 gene expression as a stress index to ocular irritation. Curr Eye Res 1999;19:115-122.
28. Miyamura N, Ogawa T, Boylan S et al. Topographic and age-dependent expression of heme oxygenase-1 and catalase in the human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2004;45:1562-1565.
29. Demir MN, Demir ZA, Yalçin Tök O et al. Oxidative stress of intracameral lidocaine and levobupivacaine on ocular tissues. Br J Ophthalmol 2010;94:1083-1087.
30. Erdurmus M, Yagci R, Atis Ö et al. Antioxidant status and oxidative stress in primary open angle glaucoma and pseu-doexfoliative glaucoma. Curr Eye Res 2011;36:713-718.
31. Abraham NG, Da Silva JL, Dunn MW et al. Retinal pigment epithelial cell-based gene therapy against hemoglobin toxic-ity. Int J Mol Med 1998;1:657-663.
32. Gong N, Ecke I, Mergler S et al. Gene transfer of cyto-protec-tive molecules in corneal endothelial cells and cultured corneas: analysis of protective effects in vitro and in vivo. Biochem Biophys Res Commun 2007;357:302-307.
33. Sun MH, Pang JH, Chen SL et al. Photoreceptor protection against light damage by AAV-mediated overex-pression of heme oxygenase-1. Invest Ophthalmol Vis Sci 2007;48:5699-5707.
34. Shyong MP, Lee FL, Hen WH et al. Viral delivery of heme oxygenase-1 attenuates photoreceptor apoptosis in an experimental model of retinal detachment. Vision Res 2008;48:2394-2402.
35. da Silva JL, Stoltz RA, Dunn MW et al. Diminished heme oxygenase-1 mRNA expression in RPE cells from diabetic donors as quantitated by competitive RT/PCR. Curr Eye Res 1997;16:380-386.
36. Hanneken A, Lin FF, Johnson J et al. Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest Ophthalmol Vis Sci 2006;47:3164-3177.
37. 2-induced oxidative stress by increasing catalase, SOD-1, and HO-1 expression. Mol Vis 2010;16:1467-1474.
38. Johnson J, Maher P, Hanneken A. The favonoid, eriodictyol, induces long-term protection in ARPE-19 cells through its effects on Nrf2 activation and phase 2 gene expression. Invest Ophthalmol Vis Sci 2009;50:2398-2406.
39. Zhu L, Liu Z, Feng Z et al. Hydroxytyrosol protects against oxidative damage by simultaneous activation of mito-chondrial biogenesis and phase II detoxifying enzyme systems in retinal pigment epithelial cells. J Nutr Biochem 2010;21:1089-1098.
40. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005;57:585-630.
41. Fan W, Huang F, Wu Z et al. Carbon monoxide: a gas that modulates nociception. J Neurosci Res 2011;89:802-807.
42. Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 1994;14:5147-5159.
43. Kajimura M, Shimoyama M, Tsuyama S et al. Visualization of gaseous monoxide reception by soluble guanylate cyclase in the rat retina. FASEB J 2003;17:506-508.
44. Otterbein LE, Bach FH, Alam J et al. Carbon monoxide has anti-infammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000;6:422-428.
45. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-infammatory effect of interleukin-10 in mice. Nat Med 2002;8:240-246.
46. Yachie A, Niida Y, Wada T et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 defciency. J Clin Invest 1999;103:129-135.
47. Chin BY, Otterbein LE. Carbon monoxide is a poison. to microbes! CO as a bactericidal molecule. Curr Opin Pharmacol 2009;9:490-500.
48. Snyder SH, Barañano DE. Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology 2001;25:294-298.
49. Stocker R, Yamamoto Y, McDonagh AF et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-1046.
50. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005;39:1-25.
51. Fondevila C, Shen XD, Tsuchiyashi S et al. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 2004;40:1333-1341.
52. Clark JE, Foresti R, Sarathchandra P et al. Heme oxy-genase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000;278:H643-H651.
53. Nakao A, Otterbein LE, Overhaus M et al. Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology 2004;127:595-606.
54. Bellner L, Vitto M, Patil KA et al. Exacerbated cor-neal infammation and neovascularization in the HO-2 null mice is ameliorated by biliverdin. Exp Eye Res 2008;87:268-278.
55. Willis D, Moore AR, Frederick R et al. Heme oxygenase: a novel target for the modulation of the infammatory response. Nat Med 1996;2:87-90.
56. Hadziahmetovic M, Song Y, Ponnuru P et al. Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest Ophthalmol Vis Sci 2011;52:109-118.
57. Picard E, Ranchon-Cole I, Jonet L et al. Light-induced retinal degeneration correlates with changes in iron metabolism gene expression, ferritin level, and aging. Invest Ophthalmol Vis Sci 2011;52:1261-1274.
58. Balla G, Jacob HS, Balla J et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992;267: 18148-18153.
59. Orino K, Lehman L, Tsuji Y et al. Ferritin and the response to oxidative stress. Biochem J 2001;357:241-247.
60. Cermak J, Balla J, Jacob HS et al. Tumor cell heme uptake induces ferritin synthesis resulting in altered oxidant sensitivity: possible role in chemotherapy effcacy. Cancer Res 1993;53:5308-5313.
61. Hunt RC, Hunt DM, Gaur N et al. Hemopexin in the human retina: protection of the retina against heme-mediated toxic-ity. J Cell Physiol 1996;168:71-80.
62. Otterbein LE, Soares MP, Yamashita K et al. Heme oxygen-ase-1: unleashing the protective properties of heme. Trends Immunol 2003;24:449-455.
63. Patil K, Bellner L, Cullaro G, Gotlinger KH et al. Heme oxygenase-1 induction attenuates corneal infammation and accelerates wound healing after epithelial injury. Invest Ophthalmol Vis Sci 2008;49:3379-3386.
64. Rossi S, D'Amico M, Capuano A, Romano M et al. Hyperglycemia in streptozotocin-induced diabetes leads to persistent infammation and tissue damage following uve-itis due to reduced levels of ciliary body heme oxygenase-1. Mediators Infamm 2006;2006:60285.
65. Biteman B, Hassan IR, Walker E et al. Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating infammation during corneal wound healing. FASEB J 2007;21:2257-2266.
66. Bellner L, Patil KA, Castellano K et al. Targeted suppression of HO-2 gene expression impairs the innate anti-infamma-tory and repair responses of the cornea to injury. Mol Vis 2011;17:1144-1152.
67. Halilovic A, Patil KA, Bellner L et al. Knockdown of heme oxygenase-2 impairs corneal epithelial cell wound healing. J Cell Physiol 2011;226:1732-1740.
68. Gronert K. Resolution, the grail for healthy ocular infamma-tion. Exp Eye Res 2010;91:478-485.
69. Sun MH, Pang JH, Chen SL et al. Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1. Invest Ophthalmol Vis Sci 2010;51:4798-4808.
70. Organisciak DT, Darrow RM, Barsalou L et al. Light history and age-related changes in retinal light damage. Invest Ophthalmol Vis Sci 1998;39:1107-1116.
71. Frank RN, Amin RH, Puklin JE. Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neo-vascular age-related macular degeneration. Am J Ophthalmol 1999;127:694-709.
72. Udono-Fujimori R, Takahashi K, Takeda K et al. Expression of heme oxygenase-1 is repressed by interferon-gamma and induced by hypoxia in human retinal pigment epithelial cells. Eur J Biochem 2004;271:3076-3084.
73. Chen W, Hunt DM, Lu H et al. Expression of antioxidant protective proteins in the rat retina during prenatal and postnatal development. Invest Ophthalmol Vis Sci 1999;40:744-751.
74. Sacca GB, Sáenz DA, Jaliffa CO et al. Photic regulation of heme oxygenase activity in the golden hamster retina: involvement of dopamine. J Neurochem 2003;85:534-542.
75. Privitera MG, Potenza M, Bucolo C et al. Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits. J Ocul Pharmacol Ther 2007;23:232-239.
76. Stagni E, Privitera MG, Bucolo C et al. A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits. Br J Ophthalmol 2009;93:254-257.
77. Bucolo C, Drago F. Carbon monoxide and the eye: implications for glaucoma therapy. Pharmacol Ther 2011;130: 191-201.
78. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro-oncology 2005;7:452-464.
79. Geraldes P, Yagi K, Ohshiro Y et al. Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway. J Biol Chem 2008;283:34327-34336.
80. Hammes HP, Bartmann A, Engel L et al. Antioxidant treatment of experimental diabetic retinopathy in rats with nica-nartine. Diabetologia 1997;40:629-634.
81. Arden GB, Sivaprasad S. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev 2011;7:291-304.
82. Grochot-Przeczek A, Dulak J, Jozkowicz A. Heme oxygen-ase-1 in neovascularisation: a diabetic perspective. Thromb Haemost 2010;104:424-431.
83. Yong PH, Zong H, Medina RJ et al. Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy. Mol Vis 2010;16:2524-2538.
84. Szabo ME, Gallyas E, Bak I et al. Heme oxygenase-1-related carbon monoxide and favonoids in ischemic/reperfused rat retina. Invest Ophthalmol Vis Sci 2004;45:3727-3732.
85. Peng PH, Chao HM, Juan SH et al. Pharmacological preconditioning by low dose cobalt protoporphyrin induces heme oxygenase-1 overexpression and alleviates retinal ischemia-reperfusion injury in rats. Curr Eye Res 2011;36:238-246.
86. Peng PH, Ko ML, Chen CF et al. Haem oxygenase-1 gene transfer protects retinal ganglion cells from ischaemia/reper-fusion injury. Clin Sci 2008;115:335-342.
87. Bucolo C, Drago F. Focus on molecules: heme oxygenase-1. Exp Eye Res 2009;89:822-823.
88. Noda M, Fujita K, Lee CH et al. The Principle and the Potential Approach to ROS-Dependent Cytotoxicity by Non-Pharmaceutical Therapies: optimal use of Medical Gases with Antioxidant Properties. Curr Pharm Des 2011.
89. Abraham NG, da Silva JL, Lavrovsky Y et al. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci 1995;36:2202-2210.
90. Liu MM, Tuo J, Chan CC. Gene therapy for ocular diseases. Br J Ophthalmol 2011;95:604-612.